Stay updated with breaking news from Wolfram Carius. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Home/News archive/Siegfried increases distribution to the shareholders and all proposals of the Board of Directors are approved Back to overview Media Release...
Media Release April 20, 2023 Siegfried increases distribution and appoints new board member Siegfried Holding AG's... | April 20, 2023
Can Bayer’s “arm’s-length model” for acquired companies help turn the century-and-a-half year-old Big Pharma into a leader in...
German pharma company announces progress in its 'two-pronged' cell and gene therapy approach to Parkinson's disease - News - PharmaTimes
Bayer AG announced today that BlueRock Therapeutics (BlueRock), a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, successfully administered the first dose of its pluripotent stem cell-derived dopaminergic neurons, named DA01, to a Parkinson’s disease patient in their open-label ...